news

Media

EchoSens in the news...

Our most recent press releases

15/04/2010 | EASL 2010: To Broaden Access to Examinations, Echosens, a World Leader in Elastography, Presents an Addition to Its Fibroscan® Product Line.

On the occasion of the 2010 edition of the European Association for the Study of the Liver (EASL) conference, Echosens, a pioneer and major player in the field of non-invasive hepatology diagnosis, introduces its new research and development focus with the launching of the latest addition to the Echosens product line, the FibroScan® 402.

Link to the release »

05/02/2010 | FibroScan® expands its application to NASH / NAFLD patients.

To meet the urgent need for non invasive alternative two teams of experts from France (head by Pr de Ledinghen) and Hong Kong (head by Pr Wong) demonstrate that the FibroScan® can be the revolutionary tool that the clinical practitioners dream of.

Link to the release »

05/02/2010 | A highly representative FibroScan® presence at the GASL Congress.

A highly representative FibroScan® presence at the GASL Congress.

Link to the release »

30/10/2009 | Echosens is a major world actor in Elastography.

Last month, at the Institute of Electrical and Electronics Engineers (IEEE) Conference in Rome, Echosens presented a series of papers and posters on its research work, including Viscosity and Micro-Elastography. Some of its new applications will also be presented during the American Association for the Study of Liver Disease (AASLD) in Boston, from October 30 to November 3, 2009.

Link to the release »

09/09/2009 | Canada approves FibroScan and its 3 probes.

The FibroScan^® with all its 3 probes has received market clearance in Canada. This occurs right after the worldwide launch of the XL Probe.

Link to the release »

30/06/2009 | Echosens launches the XL Probe.

Now with the new XL probe, all patients can be included even obese thanks to a complete software, hardware and training package of innovation & optimization.

Link to the release »

03/11/2008 | New global solution for measuring hepatic fibrosis to obese patients presented by Echosens at AASLD.

During the annual meeting of the AASLD (American Association for the Study of Liver Diseases) in San Francisco, Echosens has launched a dedicated device for measuring hepatic fibrosis in patients with BMI (Body Mass Index) > 30 kg/m2.

Link to the release »

Press kit

Pulse elastography: FibroScan®

In 2010, the range is being extended: Echosens is putting the new FibroScan®402 on the market. This is a lightweight, compact unit to satisfy the needs of doctors working in towns, small hospitals, and clinics.

Link to the press kit »

Need information? Contact us by e-mail at communication@echosens.com